How much more did provincial drug plans spend this year? Costs were driven by an increase in drug prices, as well as dispensing costs. COVID-19 shows up in Canadian wildlife for first time with three Quebec deer infectedUntil more is known, it says anyone exposed to respiratory tissues and fluids from deer should wear a well-fitting mask and avoid splashing of fluids as much as possible. Is sotrovimab neutralizing antibody for early COVID-19 available in Canada? GSK continues to work with provinces and territories to make sotrovimab available to appropriate patients. Doctor as patient: Six months into a Parkinson's diagnosis Dr. Mark Wise is coming up on the six-month mark after his Parkinson's disease diagnosis. Focus on immune system health, not age, when discussing vaccines with older adults The survey, conducted during July and August 2021, included 16,000 respondents from eight countries who answered questions online. Third monoclonal antibody approved for treating mild/moderate COVID-19 in high-risk outpatients Health Canada grants Interim Order authorization for GSK’s single-dose monoclonal antibody, sotrovimab, for adults and adolescents. Mental health impact of COVID-19 outlasts physical illness: studies What we know so far about Quebec-headquartered Medicago's plant-based vaccine candidate The roots of Canada's COVID-19 vaccine shortage go back decades A look at the seven vaccines Canada has pre-ordered First Previous 6 7 8 9 10 Next Last
